Induction of suppressor cells in mice by cyclophosphamide. 1978

M F Poupon, and J P Kolb, and G Lespinats

The injection of a single sublethal dose of cyclophosphamide (CY) into adult C3H/He mice induced splenic atrophy followed by considerable hypertrophy. During the phase of splenomegaly, the in vitro reactivity of spleen cells to the mitogens phytohaemagglutin and lipopolysaccharide was drastically decreased. Furthermore, the spleen cell population from CY-treated mice contained suppressor cells capable of inhibiting the in vitro reactivity of normal lymphocytes to these mitogens. After the removal of adherent cells, the suppressive activity was completely absent from the remaining fraction. The suppressive activity was also abolished after treatment of spleen cells with anti-immunoglobulin antiserum plus complement (C). After treatment with anti-Thy 1-2 antiserum plus C, the suppressive activity was not modified. Nude mice, B mice, young and old NZB mice, also developed suppressor cells with similar functional characteristics when treated with CY. However, in Nude mice the suppressor cells were not adherent and did not bear surface Ig. After fractionation of spleen cells by velocity sedimentation, the suppressive activity was detected in the fastest fraction with a velocity over 5 mm/h.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008814 Mice, Inbred NZB An inbred strain of mouse that is widely used as a model for AUTOIMMUNE DISEASES such as SYSTEMIC LUPUS ERYTHEMATOSUS. Mice, NZB,Mouse, Inbred NZB,Mouse, NZB,Inbred NZB Mice,Inbred NZB Mouse,NZB Mice,NZB Mice, Inbred,NZB Mouse,NZB Mouse, Inbred
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M F Poupon, and J P Kolb, and G Lespinats
January 1980, Annales d'immunologie,
M F Poupon, and J P Kolb, and G Lespinats
August 1982, Immunopharmacology,
M F Poupon, and J P Kolb, and G Lespinats
August 1992, Anti-cancer drugs,
M F Poupon, and J P Kolb, and G Lespinats
February 1978, Nature,
M F Poupon, and J P Kolb, and G Lespinats
February 1985, Journal of immunology (Baltimore, Md. : 1950),
M F Poupon, and J P Kolb, and G Lespinats
January 1979, International archives of allergy and applied immunology,
M F Poupon, and J P Kolb, and G Lespinats
January 1993, Immunopharmacology,
M F Poupon, and J P Kolb, and G Lespinats
January 1989, Folia biologica,
Copied contents to your clipboard!